1152 related articles for article (PubMed ID: 10528210)
1. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
[TBL] [Abstract][Full Text] [Related]
2. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
[TBL] [Abstract][Full Text] [Related]
4. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
5. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 1996 May; 39(5):797-809. PubMed ID: 8639177
[TBL] [Abstract][Full Text] [Related]
6. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
[TBL] [Abstract][Full Text] [Related]
8. Synergistic protection against cartilage destruction by low dose prednisolone and interleukin-10 in established murine collagen arthritis.
Joosten LA; Helsen MM; Saxne T; Heinegård D; van de Putte LB; van den Berg WB
Inflamm Res; 1999 Jan; 48(1):48-55. PubMed ID: 9987683
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis.
Quattrocchi E; Walmsley M; Browne K; Williams RO; Marinova-Mutafchieva L; Buurman W; Butler DM; Feldmann M
J Immunol; 1999 Jul; 163(2):1000-9. PubMed ID: 10395698
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of daily compared to intermittent administration of IL-1Ra for protection against bone and cartilage destruction in collagen-challenged mice.
Inoue K; Masuko-Hongo K; Okamoto M; Nishioka K
Clin Exp Rheumatol; 2003; 21(1):33-9. PubMed ID: 12673887
[TBL] [Abstract][Full Text] [Related]
11. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.
Cook AD; Braine EL; Campbell IK; Rich MJ; Hamilton JA
Arthritis Res; 2001; 3(5):293-8. PubMed ID: 11549370
[TBL] [Abstract][Full Text] [Related]
12. Local IL-13 gene transfer prior to immune-complex arthritis inhibits chondrocyte death and matrix-metalloproteinase-mediated cartilage matrix degradation despite enhanced joint inflammation.
Nabbe KC; van Lent PL; Holthuysen AE; Sloëtjes AW; Koch AE; Radstake TR; van den Berg WB
Arthritis Res Ther; 2005; 7(2):R392-401. PubMed ID: 15743487
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy.
Williams RO; Marinova-Mutafchieva L; Feldmann M; Maini RN
J Immunol; 2000 Dec; 165(12):7240-5. PubMed ID: 11120857
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein.
Banda NK; Vondracek A; Kraus D; Dinarello CA; Kim SH; Bendele A; Senaldi G; Arend WP
J Immunol; 2003 Feb; 170(4):2100-5. PubMed ID: 12574381
[TBL] [Abstract][Full Text] [Related]
15. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
[TBL] [Abstract][Full Text] [Related]
16. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
[TBL] [Abstract][Full Text] [Related]
17. Suppressive effects of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice.
Shin SS; Jin M; Jung HJ; Kim B; Jeon H; Choi JJ; Kim JM; Cho BW; Chung SH; Lee YW; Song YW; Kim S
Rheumatology (Oxford); 2003 May; 42(5):665-72. PubMed ID: 12709543
[TBL] [Abstract][Full Text] [Related]
18. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction.
Joosten LA; Lubberts E; Durez P; Helsen MM; Jacobs MJ; Goldman M; van den Berg WB
Arthritis Rheum; 1997 Feb; 40(2):249-60. PubMed ID: 9041936
[TBL] [Abstract][Full Text] [Related]
19. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
[TBL] [Abstract][Full Text] [Related]
20. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis.
Saito H; Kojima T; Takahashi M; Horne WC; Baron R; Amagasa T; Ohya K; Aoki K
Arthritis Rheum; 2007 Apr; 56(4):1164-74. PubMed ID: 17393436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]